S&P 500

5.222,68

0,16%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

0RU9

Gt Biopharma (0RU9)

Gt Biopharma Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:LSE:0RU9

1

Data	Hora	Fonte	Título	Código	Companhia
12/09/2019	08:30	PR Newswire (US)	GT Biopharma Announces FDA Notification of Commencement of Enrollment in Human GTB-3550 Trike™ Phase i/ii Clinical Trial	LSE:0RU9	Gt Biopharma Inc
13/06/2019	08:30	PR Newswire (US)	GT Biopharma GTB-1550	LSE:0RU9	Gt Biopharma Inc
29/05/2019	08:30	PR Newswire (US)	GT Biopharma GTB-1550 PHASE I-II Results to be Published in Conjunction With 2019 ASCO Meeting May 31 - June 4 in Chicago	LSE:0RU9	Gt Biopharma Inc
26/03/2019	08:30	PR Newswire (US)	GT Biopharma Announces Completion of Management Restructuring	LSE:0RU9	Gt Biopharma Inc
30/08/2018	09:00	PR Newswire (US)	GT Biopharma's Chairman and Chief Executive Officer Raymond W Urbanski, M.D., Ph.D Provides Insight Into the Impact of the Re...	LSE:0RU9	Gt Biopharma Inc
29/08/2018	08:45	PR Newswire (US)	GT Biopharma's Chairman and Chief Executive Officer Provides Insight Into the Impact of the Recent Affimed/Roche-Genetech Col...	LSE:0RU9	Gt Biopharma Inc
24/08/2018	09:00	PR Newswire (US)	GT Biopharma Announces the Appointment of David Cardino, CPA, MBA as Vice President of Finance	LSE:0RU9	Gt Biopharma Inc
14/08/2018	09:00	PR Newswire (US)	GT Biopharma Announces GTBP CEO, Dr. Raymond Urbanski, to Make Presentation at the 2018 Wedbush PacGrow Healthcare Conference	LSE:0RU9	Gt Biopharma Inc
25/07/2018	09:00	PR Newswire (US)	GT Biopharma Announces the Addition of Dr. John N. Bonfiglio to its Board of Directors	LSE:0RU9	Gt Biopharma Inc
19/07/2018	09:00	PR Newswire (US)	GT Biopharma Inc. Announces Agreement with a Major Pharmaceutical Company to Study its Drug Candidate OXS-1550 in Combination...	LSE:0RU9	Gt Biopharma Inc
05/06/2018	09:00	PR Newswire (US)	GT Biopharma Announces Voluntary Lock-Up Agreements With Insiders Covering Over 52% of Outstanding Shares	LSE:0RU9	Gt Biopharma Inc
14/05/2018	08:45	PR Newswire (US)	Gt Biopharma Announces Dr. Raymond W Urbanski Elevated to President and Chief Medical Officer of the Company	LSE:0RU9	Gt Biopharma Inc
26/04/2018	09:30	PR Newswire (US)	Seasoned Financial Executive Federica O'Brien Joins GT Biopharma's Board of Directors	LSE:0RU9	Gt Biopharma Inc
24/04/2018	10:15	PR Newswire (US)	Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of Directors	LSE:0RU9	Gt Biopharma Inc
29/03/2018	10:05	PR Newswire (US)	GT Biopharma Inc. Announces >50% Enrollment in Proof-Of-Concept Clinical Trial For Its Novel Treatment For Motion Sickness	LSE:0RU9	Gt Biopharma Inc
13/02/2018	10:45	PR Newswire (US)	GT Biopharma Announces Dr. Jeffrey Miller, Renowned NK Cell Cancer Specialist, Will Present at Cell Therapy Symposia	LSE:0RU9	Gt Biopharma Inc
24/01/2018	11:39	PR Newswire (US)	GT Biopharma, Inc. Issues Letter to Shareholders	LSE:0RU9	Gt Biopharma Inc
18/12/2017	13:27	PR Newswire (US)	GT Biopharma, Inc. Files Application for NASDAQ Capital Market Listing	LSE:0RU9	Gt Biopharma Inc